PT - JOURNAL ARTICLE AU - Willans, Robert AU - Allsopp, Gail AU - Jonsson, Pall AU - Glen, Fiona AU - Macleod, John AU - Wei, Yinghui AU - Greaves, Felix AU - Bacon, Sebastian AU - Mehrkar, Amir AU - Walker, Alex AU - MacKenna, Brian AU - Fisher, Louis AU - Goldacre, Ben AU - The OpenSAFELY Collaborative AU - The CONVALESCENCE Collaborative TI - Primary Care Post-COVID syndrome Diagnosis and Referral Coding AID - 10.1101/2023.05.23.23289798 DP - 2023 Jan 01 TA - medRxiv PG - 2023.05.23.23289798 4099 - http://medrxiv.org/content/early/2023/05/24/2023.05.23.23289798.short 4100 - http://medrxiv.org/content/early/2023/05/24/2023.05.23.23289798.full AB - Introduction Guidelines for diagnosing and managing Post-COVID syndrome have been rapidly developed. Consistency of the application of these guidelines in primary care is unknown. Electronic health records provide an opportunity to review the use of codes relating to Post-COVID syndrome. This paper explores the use of primary care records as a surrogate uptake measure for NICE’s rapid guideline “managing the long-term effects of COVID-19” by measuring the use of Post-COVID syndrome diagnosis and referral codes in the pathway.Method With the approval of NHS England we used routine clinical data from the OpenSafely-EMIS/-TPP platforms. Counts of Post-COVID syndrome diagnosis and referral codes were generated from a cohort of all adults, establishing numbers of diagnoses and referrals following diagnosis. The relationship between Post-COVID syndrome diagnosis and referral codes was explored with reference to NICE’s rapid guideline.Results Of over 45 million patients, 69,220 (0.15%) had a Post-COVID syndrome diagnostic code, and 67,741 (0.15%) had a referral code. 78% of referral codes did not have an associated diagnosis code. 79% of diagnosis codes had no subsequent referral code. Only 18,633 (0.04%) had both. There were higher rates of both diagnosis and referral in those who were more deprived, female and some ethnic groups.Discussion This study demonstrates variation in diagnosis and referral coding rates for Post-COVID syndrome across different patient groups. The results, with limited crossover of referral and diagnostic codes, suggest only one type of code is usually recorded. Recording one code limits the use of routine data for monitoring Post-COVID syndrome diagnosis and management, but suggests several areas for improvement in coding. Post-COVID syndrome coding, particularly diagnosis coding, needs to improve before administrators and researchers can use it to evaluate care pathways.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care services (CONVALESCENCE) programme, funded by NIHR (COV-LT-0009).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval granted through the NICE Research Governance process and external ethical reviewI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data in the manuscript has been extracted from the OpenSAFELY-EMIS-TPP platform. See https://www.opensafely.org/about/ for details.